These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6202686)

  • 21. Comparison of the inhibition of thrombin by three plasma protease inhibitors.
    Downing MR; Bloom JW; Mann KG
    Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children.
    Mitchell L; Piovella F; Ofosu F; Andrew M
    Blood; 1991 Nov; 78(9):2299-304. PubMed ID: 1718494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin.
    Straight DL; Hassett MA; McKee PA
    Biochemistry; 1985 Jul; 24(15):3902-7. PubMed ID: 2413880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural proteinase inhibitors: blood coagulation inhibition and evolutionary relationships.
    Bikfalvi A; Beress L
    Comp Biochem Physiol B; 1987; 87(3):435-41. PubMed ID: 2441925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Pratt CW; Pizzo SV
    Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the inhibition of free and elastin-bound human pancreatic elastase by alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
    Laurent P; Bieth JG
    Biochim Biophys Acta; 1989 Feb; 994(3):285-8. PubMed ID: 2465784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
    Heck LW; Kaplan AP
    J Exp Med; 1974 Dec; 140(6):1615-30. PubMed ID: 4547783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determination of antithrombin III, alpha 2-macroglobulin and alpha 2-antiplasmin in plasma by laser nephelometry.
    Schmitz-Huebner U; Nachbar J; Asbeck F
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):221-5. PubMed ID: 6155426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
    Dubin A; Potempa J; Travis J
    Prep Biochem; 1990; 20(1):63-74. PubMed ID: 1694995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the interactions of human pancreatic elastase 2 with human alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
    Davril M; Laine A; Hayem A
    Biochem J; 1987 Aug; 245(3):699-704. PubMed ID: 3499146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antithrombin III, alpha 1-proteinase inhibitor and heparin on amidolytic activity of nerve growth factor (7S-NGF).
    Long WF; Williamson FB
    Biochem Biophys Res Commun; 1983 May; 113(1):108-13. PubMed ID: 6602610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of horse plasma antithrombin III and alpha 1-proteinase inhibitor with some serine proteinases.
    Koj A; Kurdowska A
    Acta Biol Med Ger; 1981; 40(10-11):1561-70. PubMed ID: 6979142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
    Pieters J; Willems G; Hemker HC; Lindhout T
    J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.